Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model
Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by ci...
Saved in:
Published in | Chinese journal of integrative medicine Vol. 21; no. 7; pp. 537 - 541 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Beijing
Chinese Association of Traditional and Western Medicine
01.07.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-0415 1993-0402 1993-0402 |
DOI | 10.1007/s11655-014-1622-4 |
Cover
Abstract | Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. |
---|---|
AbstractList | Objective
To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.
Methods
The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.
Results
Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (
P
=0.0212), 48.2% (
P
=0.0108), and 52.7% (
P
=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (
P
=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.
Conclusions
Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.OBJECTIVETo investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.METHODSThe HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.RESULTSGroups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.CONCLUSIONSOrally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. |
Author | 王虎军 高伟成 马少林 |
AuthorAffiliation | Department of Plastic Surgery of the First Teaching Hospital, Xinjiang Medical University, Urumqi 830054, China |
Author_xml | – sequence: 1 fullname: 王虎军 高伟成 马少林 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24449084$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1PHDEQhq2IKHzlB6SJrFQ0S_y96_KEjhAJFClAbXnXYzDas-_s3Ujk1-PLXSgoKEYeaZ53xnqO0UFMERD6Qsk5JaT9XihVUjaEioYqxhrxAR1RrXlDBGEHtVctqz2Vh-i4lCdCZKuI_IQOmRBCk04cobul9zBMOHm86GPKKzviW_vHWXwzx79hg1PEV89ryFNO68cw4NvBZny5BadQZyHiBf5t-z5MeFknN8nBeIo-ejsW-Lx_T9D95fLu4qq5_vXj58XiuhmEoFPDOQCDzrGBCAu67Rxvew-60xw0d8QqTWtp1_UOhLedJJYLJT14J1jX8hN0ttu7zmkzQ5nMKpQBxtFGSHMxVGlJO9IyUdGve3TuV-DMOoeVzc_mv4kK0B0w5FRKBv-KUGK2ts3Otqm2zda22WbaN5khTP-8TNmG8d0k2yVLvRIfIJunNOdYZb0b-rY_95jiw6bmXv-olBSMaUb4C9ranQc |
CitedBy_id | crossref_primary_10_1038_srep27831 crossref_primary_10_2147_CCID_S489625 crossref_primary_10_3389_fsurg_2022_711094 crossref_primary_10_1080_2000656X_2020_1814312 crossref_primary_10_1016_j_indcrop_2022_115113 |
Cites_doi | 10.1007/s00266-008-9276-x 10.1111/j.1365-2230.2007.02636.x 10.2119/molmed.2009.00153 10.2515/therapie:2004083 10.1097/PRS.0b013e3182865c3f 10.1097/PRS.0b013e31823aea10 10.1111/j.1472-8206.2005.00342.x 10.1007/s12079-013-0195-5 10.1631/jzus.B1200077 10.1111/j.1472-8206.2004.00249.x 10.1590/S0100-879X2011000500004 10.1007/s00266-006-0253-y 10.1007/s00403-010-1114-8 10.1111/j.1365-4632.2012.05704.x 10.1111/j.1524-475X.2007.00219.x 10.1016/j.mvr.2008.09.005 10.1016/j.fitote.2004.05.005 10.1016/j.mvr.2008.08.007 10.1093/ecam/nep059 10.3892/mmr.2013.1278 10.3748/wjg.v13.i22.3056 |
ContentType | Journal Article |
Copyright | Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2015 |
Copyright_xml | – notice: Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2015 |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s11655-014-1622-4 |
DatabaseName | 中文期刊服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model |
EISSN | 1993-0402 |
EndPage | 541 |
ExternalDocumentID | 24449084 10_1007_s11655_014_1622_4 665422920 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29B 29~ 2B. 2C~ 2J2 2JN 2JY 2KG 2KM 2LR 2RA 2VQ 2~H 30V 36B 4.4 406 408 40D 40E 5GY 5VR 5VS 6NX 6PF 92F 92I 92L 93N 93R 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACBMV ACBRV ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACUDM ACVWB ACWMK ACZOJ ADHIR ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFLOW AFNRJ AFQWF AFUIB AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 DDRTE DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EMB EMOBN ESBYG F5P FA0 FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR I~X I~Z J-C JBSCW JZLTJ LLZTM M4Y MA- NDZJH NPVJJ NQJWS NU0 O9- P9S PF0 PT4 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCL SCLPG SDH SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SV3 SZ9 SZN T13 T16 TCJ TGQ TSG TT1 TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 W91 WFFXF WK8 YLTOR Z7U ZMTXR ZOVNA ~A9 ~WA -SE -S~ AACDK AAJBT AASML AAXDM AAYZH ABAKF ABQSL ACDTI ACPIV AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU CAJEE H13 Q-- SJYHP U1G U5O AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 ABRTQ |
ID | FETCH-LOGICAL-c441t-33ee2e8d2c04ae978d37bfe9893e93d0a691a699d8bde4fa850a3465fefd42873 |
IEDL.DBID | AGYKE |
ISSN | 1672-0415 1993-0402 |
IngestDate | Fri Jul 11 06:05:58 EDT 2025 Wed Feb 19 01:57:24 EST 2025 Tue Jul 01 01:08:58 EDT 2025 Thu Apr 24 23:04:10 EDT 2025 Fri Feb 21 02:35:54 EST 2025 Wed Feb 14 10:29:58 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Abnormal Savda Munziq ultrastructure hypertrophic scar |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-33ee2e8d2c04ae978d37bfe9893e93d0a691a699d8bde4fa850a3465fefd42873 |
Notes | 11-4928/R hypertrophic scar, Abnormal Savda Munziq, ultrastructure Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model. Methods: The HTS rabbit model was created by circular full- thickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy. Results: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that high- dose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually. Conclusions: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS. WANG Hu-jun , GAO Wei-cheng, and MA Shao-lin (Department of Plastic Surgery of the First Teaching Hospital, Xinjiang Medical University, Urumqi 830054, China) ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24449084 |
PQID | 1695180724 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1695180724 pubmed_primary_24449084 crossref_primary_10_1007_s11655_014_1622_4 crossref_citationtrail_10_1007_s11655_014_1622_4 springer_journals_10_1007_s11655_014_1622_4 chongqing_primary_665422920 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-07-01 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Beijing |
PublicationPlace_xml | – name: Beijing – name: China |
PublicationTitle | Chinese journal of integrative medicine |
PublicationTitleAbbrev | Chin. J. Integr. Med |
PublicationTitleAlternate | Chinese Journal of Integrative Medicine |
PublicationYear | 2015 |
Publisher | Chinese Association of Traditional and Western Medicine |
Publisher_xml | – name: Chinese Association of Traditional and Western Medicine |
References | Zhu, Ding, Shankowsky, Tredget (CR15) 2013; 7 Foley, Ehrlich (CR18) 2013; 131 Choi, Hwang (CR10) 2004; 75 Atiyeh (CR20) 2007; 31 Song, Bian, Lai, Chen, Zhao (CR17) 2011; 44 Wang, Liu, Qing, Lu (CR5) 2009; 77 Issa, Kassuga, Chevrand, Pires (CR16) 2013; 52 Verrecchia, Mauviel (CR19) 2007; 13 Upur, Yusup, Baudrimont, Umar, Berke, Yimit (CR13) 2011; 25 Gauglitz, Korting, Pavicic, Ruzicka, Jeschke (CR3) 2011; 17 Armour, Scott, Tredget (CR4) 2007; 15 Yusup, Upur, Umar, Berke, Yimit, Lapham (CR9) 2011; 2011 Ko, Kim, Zhao, Hong, Mustoe (CR14) 2012; 129 Deng, Zheng, Wan, Zhang, Ding, Mao (CR8) 2013; 7 Tang, Zhu, Liang, Bi, Hu, Chen (CR7) 2011; 303 Ren, Hu, Li, Jiang, Hu, Han (CR6) 2013; 14 Yusup, Upur, Baudrimont, Umar, Kader, Begaud (CR11) 2005; 19 Widgerow, Chait, Stals, Stals, Candy (CR1) 2009; 33 Upur, Yusup, Umar, Moore (CR21) 2004; 59 Qi, Xie, Pan, Xu, Li, Tang (CR2) 2008; 33 Yusup, Upur, Umar, Moore (CR12) 2004; 18 HT Ren (1622_CR6) 2013; 14 JH Ko (1622_CR14) 2012; 129 GG Gauglitz (1622_CR3) 2011; 17 EM Choi (1622_CR10) 2004; 75 F Verrecchia (1622_CR19) 2007; 13 AD Widgerow (1622_CR1) 2009; 33 XQ Wang (1622_CR5) 2009; 77 A Yusup (1622_CR9) 2011; 2011 A Yusup (1622_CR12) 2004; 18 BS Atiyeh (1622_CR20) 2007; 31 H Upur (1622_CR21) 2004; 59 H Upur (1622_CR13) 2011; 25 SH Qi (1622_CR2) 2008; 33 C Deng (1622_CR8) 2013; 7 A Armour (1622_CR4) 2007; 15 MC Issa (1622_CR16) 2013; 52 B Tang (1622_CR7) 2011; 303 Z Zhu (1622_CR15) 2013; 7 TT Foley (1622_CR18) 2013; 131 A Yusup (1622_CR11) 2005; 19 R Song (1622_CR17) 2011; 44 17576505 - Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4 15351109 - Fitoterapia. 2004 Sep;75(6):557-65 23414164 - Int J Dermatol. 2013 Mar;52(3):367-70 19561161 - Evid Based Complement Alternat Med. 2011;2011:152015 20927486 - Mol Med. 2011 Jan-Feb;17(1-2):113-25 23504443 - J Cell Commun Signal. 2013 Dec;7(4):239-52 23629085 - Plast Reconstr Surg. 2013 May;131(5):1036-44 18955370 - Evid Based Complement Alternat Med. 2011;2011:251424 17589920 - World J Gastroenterol. 2007 Jun 14;13(22):3056-62 15559555 - Therapie. 2004 Jul-Aug;59(4):483-4 21240513 - Arch Dermatol Res. 2011 Oct;303(8):563-72 19048338 - Aesthetic Plast Surg. 2009 Jul;33(4):533-43 23338822 - Mol Med Rep. 2013 Mar;7(3):785-90 18838083 - Microvasc Res. 2009 Mar;77(2):204-11 18201262 - Clin Exp Dermatol. 2008 Mar;33(2):171-5 23463765 - J Zhejiang Univ Sci B. 2013 Mar;14(3):224-30 15312154 - Fundam Clin Pharmacol. 2004 Aug;18(4):471-6 17727469 - Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17 16011734 - Fundam Clin Pharmacol. 2005 Aug;19(4):465-72 21445528 - Braz J Med Biol Res. 2011 May;44(5):402-10 22286441 - Plast Reconstr Surg. 2012 Feb;129(2):252e-261e |
References_xml | – volume: 33 start-page: 533 year: 2009 end-page: 543 ident: CR1 article-title: Multimodality scar management program. publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-008-9276-x – volume: 33 start-page: 171 year: 2008 end-page: 175 ident: CR2 article-title: Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts. publication-title: Clin Exp Dermatol doi: 10.1111/j.1365-2230.2007.02636.x – volume: 25 start-page: 14 year: 2011 end-page: 24 ident: CR13 article-title: Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human Hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine. publication-title: Evid Based Complement Alternat Med – volume: 17 start-page: 113 year: 2011 end-page: 125 ident: CR3 article-title: Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. publication-title: Mol Med doi: 10.2119/molmed.2009.00153 – volume: 59 start-page: 483 year: 2004 end-page: 484 ident: CR21 article-title: Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. publication-title: Therapie doi: 10.2515/therapie:2004083 – volume: 131 start-page: 1036 year: 2013 end-page: 1044 ident: CR18 article-title: Through gap junction communications, co-cultured mast cells and fibroblasts generate fibroblast activities allied with hypertrophic scarring. publication-title: Plast Reconstr Surg doi: 10.1097/PRS.0b013e3182865c3f – volume: 129 start-page: 252e year: 2012 end-page: 261e ident: CR14 article-title: HMG-CoA reductase inhibitors (Statins) reduce hypertrophic scar formation in a rabbit ear wounding model. publication-title: Plast Reconstr Surg doi: 10.1097/PRS.0b013e31823aea10 – volume: 19 start-page: 465 year: 2005 end-page: 472 ident: CR11 article-title: Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2005.00342.x – volume: 7 start-page: 239 year: 2013 end-page: 252 ident: CR15 article-title: The molecular mechanism of hypertrophic scar. publication-title: J Cell Commun Signal doi: 10.1007/s12079-013-0195-5 – volume: 14 start-page: 224 year: 2013 end-page: 230 ident: CR6 article-title: Endostatin inhibits hypertrophic scarring in a rabbit ear model. publication-title: J Zhejiang Univ (Chin) doi: 10.1631/jzus.B1200077 – volume: 18 start-page: 471 year: 2004 end-page: 476 ident: CR12 article-title: Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage. publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2004.00249.x – volume: 44 start-page: 402 year: 2011 end-page: 410 ident: CR17 article-title: Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor. publication-title: Braz J Med Biol Res doi: 10.1590/S0100-879X2011000500004 – volume: 2011 start-page: 152015 year: 2011 ident: CR9 article-title: Abnormal Savda Munziq, an herbal preparation of traditional Uighur medicine, may prevent 1,2-dimethylhydrazine-induced rat colon carcinogenesis. publication-title: Evid Based Complement Alternat Med – volume: 13 start-page: 3056 year: 2007 end-page: 3062 ident: CR19 article-title: Transforming growth factor-beta and fibrosis. publication-title: World J Gastroenterol – volume: 31 start-page: 468 year: 2007 end-page: 492 ident: CR20 article-title: Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-006-0253-y – volume: 303 start-page: 563 year: 2011 end-page: 572 ident: CR7 article-title: Asiaticoside suppresses collagen expression and TGFbeta/ Smad signaling through inducing Smad7 and inhibiting TGF-betaRI and TGF-betaRII in keloid fibroblasts. publication-title: Arch Dermatol Res doi: 10.1007/s00403-010-1114-8 – volume: 52 start-page: 367 year: 2013 end-page: 370 ident: CR16 article-title: Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment. publication-title: Int J Dermatol doi: 10.1111/j.1365-4632.2012.05704.x – volume: 7 start-page: 785 year: 2013 end-page: 790 ident: CR8 article-title: Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide. publication-title: Mol Med Rep – volume: 15 start-page: S6 year: 2007 end-page: S17 ident: CR4 article-title: Cellular and molecular pathology of HTS: basis for treatment. publication-title: Wound Repair Regen doi: 10.1111/j.1524-475X.2007.00219.x – volume: 77 start-page: 204 year: 2009 end-page: 211 ident: CR5 article-title: Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. publication-title: Microvasc Res doi: 10.1016/j.mvr.2008.09.005 – volume: 75 start-page: 557 year: 2004 end-page: 565 ident: CR10 article-title: Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. publication-title: Fitoterapia doi: 10.1016/j.fitote.2004.05.005 – volume: 77 start-page: 204 year: 2009 ident: 1622_CR5 publication-title: Microvasc Res doi: 10.1016/j.mvr.2008.08.007 – volume: 303 start-page: 563 year: 2011 ident: 1622_CR7 publication-title: Arch Dermatol Res doi: 10.1007/s00403-010-1114-8 – volume: 31 start-page: 468 year: 2007 ident: 1622_CR20 publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-006-0253-y – volume: 17 start-page: 113 year: 2011 ident: 1622_CR3 publication-title: Mol Med doi: 10.2119/molmed.2009.00153 – volume: 33 start-page: 533 year: 2009 ident: 1622_CR1 publication-title: Aesthetic Plast Surg doi: 10.1007/s00266-008-9276-x – volume: 19 start-page: 465 year: 2005 ident: 1622_CR11 publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2005.00342.x – volume: 52 start-page: 367 year: 2013 ident: 1622_CR16 publication-title: Int J Dermatol doi: 10.1111/j.1365-4632.2012.05704.x – volume: 131 start-page: 1036 year: 2013 ident: 1622_CR18 publication-title: Plast Reconstr Surg doi: 10.1097/PRS.0b013e3182865c3f – volume: 59 start-page: 483 year: 2004 ident: 1622_CR21 publication-title: Therapie doi: 10.2515/therapie:2004083 – volume: 15 start-page: S6 year: 2007 ident: 1622_CR4 publication-title: Wound Repair Regen doi: 10.1111/j.1524-475X.2007.00219.x – volume: 7 start-page: 239 year: 2013 ident: 1622_CR15 publication-title: J Cell Commun Signal doi: 10.1007/s12079-013-0195-5 – volume: 2011 start-page: 152015 year: 2011 ident: 1622_CR9 publication-title: Evid Based Complement Alternat Med doi: 10.1093/ecam/nep059 – volume: 25 start-page: 14 year: 2011 ident: 1622_CR13 publication-title: Evid Based Complement Alternat Med – volume: 129 start-page: 252e year: 2012 ident: 1622_CR14 publication-title: Plast Reconstr Surg doi: 10.1097/PRS.0b013e31823aea10 – volume: 14 start-page: 224 year: 2013 ident: 1622_CR6 publication-title: J Zhejiang Univ (Chin) doi: 10.1631/jzus.B1200077 – volume: 75 start-page: 557 year: 2004 ident: 1622_CR10 publication-title: Fitoterapia doi: 10.1016/j.fitote.2004.05.005 – volume: 33 start-page: 171 year: 2008 ident: 1622_CR2 publication-title: Clin Exp Dermatol doi: 10.1111/j.1365-2230.2007.02636.x – volume: 7 start-page: 785 year: 2013 ident: 1622_CR8 publication-title: Mol Med Rep doi: 10.3892/mmr.2013.1278 – volume: 18 start-page: 471 year: 2004 ident: 1622_CR12 publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2004.00249.x – volume: 13 start-page: 3056 year: 2007 ident: 1622_CR19 publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i22.3056 – volume: 44 start-page: 402 year: 2011 ident: 1622_CR17 publication-title: Braz J Med Biol Res doi: 10.1590/S0100-879X2011000500004 – reference: 23414164 - Int J Dermatol. 2013 Mar;52(3):367-70 – reference: 19048338 - Aesthetic Plast Surg. 2009 Jul;33(4):533-43 – reference: 18838083 - Microvasc Res. 2009 Mar;77(2):204-11 – reference: 23463765 - J Zhejiang Univ Sci B. 2013 Mar;14(3):224-30 – reference: 16011734 - Fundam Clin Pharmacol. 2005 Aug;19(4):465-72 – reference: 21240513 - Arch Dermatol Res. 2011 Oct;303(8):563-72 – reference: 15559555 - Therapie. 2004 Jul-Aug;59(4):483-4 – reference: 18955370 - Evid Based Complement Alternat Med. 2011;2011:251424 – reference: 23338822 - Mol Med Rep. 2013 Mar;7(3):785-90 – reference: 23504443 - J Cell Commun Signal. 2013 Dec;7(4):239-52 – reference: 18201262 - Clin Exp Dermatol. 2008 Mar;33(2):171-5 – reference: 17576505 - Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4 – reference: 17727469 - Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S6-17 – reference: 17589920 - World J Gastroenterol. 2007 Jun 14;13(22):3056-62 – reference: 22286441 - Plast Reconstr Surg. 2012 Feb;129(2):252e-261e – reference: 20927486 - Mol Med. 2011 Jan-Feb;17(1-2):113-25 – reference: 15312154 - Fundam Clin Pharmacol. 2004 Aug;18(4):471-6 – reference: 15351109 - Fitoterapia. 2004 Sep;75(6):557-65 – reference: 21445528 - Braz J Med Biol Res. 2011 May;44(5):402-10 – reference: 19561161 - Evid Based Complement Alternat Med. 2011;2011:152015 – reference: 23629085 - Plast Reconstr Surg. 2013 May;131(5):1036-44 |
SSID | ssj0057605 |
Score | 2.030677 |
Snippet | Objective: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of... Objective To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of... To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases,... |
SourceID | proquest pubmed crossref springer chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 537 |
SubjectTerms | Animals Cicatrix, Hypertrophic - drug therapy Cicatrix, Hypertrophic - pathology Disease Models, Animal Drugs, Chinese Herbal - pharmacology Drugs, Chinese Herbal - therapeutic use Ear - pathology Female Medicine Medicine & Public Health Original Article Plant Extracts - pharmacology Plant Extracts - therapeutic use Rabbits Wound Healing - drug effects 兔耳 增生性瘢痕 异常 微结构分析 成熟 超导模型 透射电子显微镜分析 高温超导 |
Title | Effect of Abnormal Savda Munziq on Hypertrophic Scar Formation in A Rabbit Ear Model |
URI | http://lib.cqvip.com/qk/86437A/201507/665422920.html https://link.springer.com/article/10.1007/s11655-014-1622-4 https://www.ncbi.nlm.nih.gov/pubmed/24449084 https://www.proquest.com/docview/1695180724 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JbtswEB00DlD0knTP0gQs0FMLBVooiTwaQdKghXupDaQnghSp2mhA2bKcQ74-Q0m0kboNkINOpIYSh8sbvFkAPhm8ktrQLd3SjFrxgEldBgmjiZZK07BwjO7oR3Y1od-u0-s-jnvpvd09Jdme1JtgtyhLnaMZDaIMLSi6A7tpxDgbwO7w66_vF_4ARgTdei5GWR4HLgLdk5n_EuJSKkwr-3uBAz68mrbw5hZX2l5Bl_sw9h_feZ78OVs16qy4-yuv4xP_7iXs9ZCUDLs19AqeGfsano960v0NjLsMx6QqyVBZh3FvyE95qyUZrezdbEEqS6ZoztZNXc2ns4IsC1mTdVQkmVkiSS2VmjUE9xVpi--8hcnlxfj8KuiLMQQFIqYmSBJjYsN0XIRUGrQ9dZKr0nDEO4YnOpQZj_DhmiltaClZGsqEZmlpSu3MsuQdDGxlzQEQlblcSFSlimeUs5zrPJWlRLFG5czQQzhe60TMu6QbwlVJjl1prUMIvZZE0ecxd-U0bsQmA7ObS4FzKdxcChT4ef2Kl_dI549e9QK3muNPpDXVaontCEdZmMfY5323JtbiECU5ChVbvnj9iv40WP5_rKMn9T6GFwjX0s5Z-AMMmnplThASNeq03wKnsDOJh_dQZQA4 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA86Qb2I3875EcGTUujatE2PQ5Sp2y5usFtImtQNRrp1nQf_el_6sSFTwUNPSV8gL8n7PX7vA6FbBSYpT92SOc0oRWhRLmPLpcSVXEhiR4bR7fb89oC8DL1hmcc9r6LdK0oyf6lXyW5N3zOBZsRq-uBBkU20BViAmrYFA6dVPb-An_O4xaYfOJbJP6-ozJ9EmIIKo0S_z2C574ZpDW2uMaW5AXraR3slcsStQtUHaEPpQ7TdLbnxI9QvChHjJMYtoQ0UneA3_iE57i7053iGE41H4HWmWZpMR-MIzyOe4mXyIh5rzHHKhRhnGI4_znvkHKPB02P_oW2VPROsCIBNZrmuUo6i0olswhW4iNINRKxCgCUqdKXN_bAJXyipkIrEnHo2d4nvxSqWxntyT1BNJ1qdISx8U7KICE-EPglpEMrA4zEHsUoEVJE6aiw3j02L2hjMNDN2TAesOrKr7WRRWW7cdL2YsFWhZKMNBtpgRhsMBN4tf6nk_TH5ptIRgxthaA6uVbKYwzigRmoHDsw5LZS3FAdgxjCdMHJfaZOVl3b--1rn_5p9jXba_W6HdZ57rw20CwjLK-J7L1AtSxfqElBMJq7yU_sF8znlYA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1JSwMxFA4uIF7EfdcInpShs2S2Y1FLXVoELfQWkknGFkqmzkw9-Ot9ma1IVfAwp2ReIC8v-R7fWxC6lPAkFalboqAZBQ-NgInYcALiCMYFMSPN6Pb6XndAHobusOpzmtXR7jUlWeY06CpNKm9NRdyaJ75ZnquDzohheeBNkWW0CrexpQ_6wG7XVzFg6SKG0fJ829C56DWt-ZMIXVxhlKi3d1j6-yO1gDwXWNPiMepsoo0KReJ2qfYttCTVNlrrVTz5DnotixLjJMZtrjQsneAX9iEY7s3U5_gdJwqPwANN8zSZjsYRziKW4iaREY8VZjhlnI9zDKaAi345u2jQuXu96RpV_wQjApCTG44jpS0DYUcmYRLcReH4PJYhQBQZOsJkXmjBF4qAC0liFrgmc4jnxjIW2pNy9tCKSpQ8QJh7unwR4S4PPRIGfih8l8UMxEruB5IcouNm8-i0rJNBdWNjW3fDOkRmvZ00qkqP6w4YEzovmqy1QUEbVGuDgsCr5pda3h-TL2odUbAOTXkwJZNZBuOAIAPTt2HOfqm8RhwAG816wsh1rU1aGXD2-1pH_5p9jtaebzv06b7_eIzWAWy5ZajvCVrJ05k8BUCT87Pi0H4BWqvpnA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Abnormal+Savda+Munziq+on+hypertrophic+scar+formation+in+a+rabbit+ear+model&rft.jtitle=Chinese+journal+of+integrative+medicine&rft.au=Wang%2C+Hu-jun&rft.au=Gao%2C+Wei-cheng&rft.au=Ma%2C+Shao-lin&rft.date=2015-07-01&rft.issn=1672-0415&rft.volume=21&rft.issue=7&rft.spage=537&rft_id=info:doi/10.1007%2Fs11655-014-1622-4&rft_id=info%3Apmid%2F24449084&rft.externalDocID=24449084 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86437A%2F86437A.jpg |